Literature DB >> 1904980

Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.

E Rubin1, S Kharbanda, H Gunji, D Kufe.   

Abstract

The epipodophyllotoxin etoposide is an inhibitor of topoisomerase II. The effects of this agent on gene expression, particularly the transcriptional induction of genes implicated in growth control, are unknown. The present results demonstrate that etoposide induces expression of the c-jun protooncogene in HL-60 myeloid leukemia cells. This induction of c-jun expression was maximal at 3 hr and was transient. Similar findings were obtained in the human U-937 myeloid leukemia cell line. Nuclear run-on assays demonstrated that the induction of c-jun expression by etoposide is regulated at the transcriptional level. The results further demonstrate that etoposide-induced c-jun expression occurs in association with the appearance of c-fos transcripts. Moreover, the c-jun gene is induced by etoposide during periods of oligonucleosomal DNA cleavage, which is characteristic of programmed cell death. These findings suggest that transcriptional induction of c-jun expression represents a signaling pathway activated in the cellular response to etoposide-induced DNA damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904980

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

Review 1.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Effect of vitamin A deficiency on the integrity of hepatocytes after partial hepatectomy.

Authors:  R P Evarts; Z Hu; N Omori; M Omori; E R Marsden; S S Thorgeirsson
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

3.  Apoptosis induced by etoposide in small-cell lung cancer cell lines.

Authors:  S Okamoto-Kubo; K Nishio; Y Heike; M Yoshida; T Ohmori; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 4.  Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells.

Authors:  W T Beck; R Kim; M Chen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage.

Authors:  S Kharbanda; P Pandey; T Yamauchi; S Kumar; M Kaneki; V Kumar; A Bharti; Z M Yuan; L Ghanem; A Rana; R Weichselbaum; G Johnson; D Kufe
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 6.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

7.  Apoptosis resistance in tumor cells.

Authors:  T Mashima; H Seimiya; Z Chen; S Kataoka; T Tsuruo
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

8.  Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.

Authors:  Y Emoto; Y Manome; G Meinhardt; H Kisaki; S Kharbanda; M Robertson; T Ghayur; W W Wong; R Kamen; R Weichselbaum
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

9.  Enhancement of Ca(2+)-dependent endonuclease activity in L1210 cells during apoptosis induced by 1-beta-D-arabinofuranosylcytosine: possible involvement of activating factor(s).

Authors:  R Takauji; A Yoshida; H Iwasaki; K Tohyama; T Ueda; T Nakamura
Journal:  Jpn J Cancer Res       Date:  1995-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.